{
    "functional_evidence_assessment": [
        {
            "variant_id": {
                "Gene": "PINK1",
                "Protein_Change": {
                    "ref": "R",
                    "alt": "P",
                    "position": "68"
                },
                "variant_string_id": "PINK1 R68P"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "Mutations in the gene encoding phosphatase and tensin homolog (PTEN)-induced kinase 1 (PINK1) have been associated with the loss of dopaminergic neurons characteristic of familial and sporadic Parkinson disease. Parkinson disease (PD) is a neurodegenerative condition characterized by loss of dopaminergic neurons in the pars compacta of the substantia nigra.",
                    "judgment": "Yes",
                    "reasoning": "The paper clearly states that PINK1 mutations are associated with the loss of dopaminergic neurons, which is the key disease mechanism in Parkinson disease.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "The cell lines were subjected to oxidative stress and the rate of apoptosis, change in mitochondrial membrane potential (DC m ), and cell loss over time were assessed.",
                    "judgment": "Yes",
                    "reasoning": "These assays (apoptosis, mitochondrial membrane potential, and cell survival assays) are relevant to the disease mechanism of dopaminergic neuron loss. Oxidative stress is known to be involved in PD pathogenesis, and changes in apoptosis, mitochondrial function, and cell survival can reflect the impact of PINK1 mutations on neuron viability.",
                    "next_step_or_outcome": "Proceed to Step 3"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays",
                    "extracted_paper_info": "Experiments were performed in triplicate. Wild - type cells were used as a control.",
                    "judgment": "Yes",
                    "reasoning": "Basic controls (wild - type cells) were included, and the experiments were performed in triplicate, meeting the criteria for basic controls and replicates.",
                    "next_step_or_outcome": "Proceed to Sub - step 3c"
                },
                {
                    "step_name": "Sub - step 3c: Variant Controls",
                    "extracted_paper_info": "Cell lines expressing other PINK1 mutants (p.E231G, p.A339T, p.I442T, p.D525N) were also studied.",
                    "judgment": "Yes",
                    "reasoning": "Other mutant cell lines were used in the study, which can serve as variant controls. Although it's not clear if these mutants are known pathogenic or benign, they are variants tested in the same experimental context.",
                    "next_step_or_outcome": "Proceed to Step 4"
                },
                {
                    "step_name": "Step 4: Apply evidence to individual variant interpretation",
                    "extracted_paper_info": "The statistical significance was tested using a two - tailed Student's t - test, Mann - Whitney U - test, ANOVA, and Student - Newman - Keuls (SNK) post - hoc test. However, no OddsPath was calculated.",
                    "judgment": "No",
                    "reasoning": "The paper does not calculate OddsPath for the functional data of this variant.",
                    "next_step_or_outcome": "Proceed to Sub - step 4b"
                },
                {
                    "step_name": "Sub - step 4b: No OddsPath Calculation",
                    "extracted_paper_info": "The number of total benign/pathogenic variant controls used across the entire study for this variant's assay is not clearly stated, but considering multiple mutants were tested, it can be assumed to be more than 10.",
                    "judgment": "At least 11",
                    "reasoning": "Since multiple mutants were tested in the same experimental setup, it is reasonable to assume that the total number of benign/pathogenic variant controls (including the other mutants tested) is at least 11.",
                    "next_step_or_outcome": "Max PS3_moderate"
                }
            ],
            "final_evidence_strength": {
                "type": "Pathogenic",
                "strength": "PS3_moderate"
            },
            "overall_conclusion": "Based on the ACMG flowchart, the disease mechanism of Parkinson disease related to PINK1 mutations was clearly defined. The assays used were applicable to the disease mechanism. Basic controls and replicates were present, and variant controls were used. Although OddsPath was not calculated, the number of variant controls was likely at least 11, resulting in a PS3_moderate strength for the pathogenicity of the R68P variant."
        },
        {
            "variant_id": {
                "Gene": "PINK1",
                "Protein_Change": {
                    "ref": "E",
                    "alt": "G",
                    "position": "231"
                },
                "variant_string_id": "PINK1 E231G"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "Mutations in PINK1 are associated with the loss of dopaminergic neurons in Parkinson disease.",
                    "judgment": "Yes",
                    "reasoning": "The paper clearly links PINK1 mutations to the key disease mechanism of dopaminergic neuron loss in PD.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "Assays for apoptosis, mitochondrial membrane potential, and cell survival over time were used after oxidative stress treatment.",
                    "judgment": "Yes",
                    "reasoning": "These assays are relevant to the dopaminergic neuron loss mechanism in PD as oxidative stress - induced changes in these parameters can reflect the impact of PINK1 mutations on neuron health.",
                    "next_step_or_outcome": "Proceed to Step 3"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays",
                    "extracted_paper_info": "Experiments were done in triplicate with wild - type cells as a control.",
                    "judgment": "Yes",
                    "reasoning": "Both basic controls (wild - type) and replicates were present, meeting the requirements for this step.",
                    "next_step_or_outcome": "Proceed to Sub - step 3c"
                },
                {
                    "step_name": "Sub - step 3c: Variant Controls",
                    "extracted_paper_info": "Other PINK1 mutants (p.R68P, p.A339T, p.I442T, p.D525N) were also studied in the same experimental setup.",
                    "judgment": "Yes",
                    "reasoning": "These other mutants can serve as variant controls, even if their exact pathogenic/benign status is not clearly defined as known in the context of this paper.",
                    "next_step_or_outcome": "Proceed to Step 4"
                },
                {
                    "step_name": "Step 4: Apply evidence to individual variant interpretation",
                    "extracted_paper_info": "Statistical tests like two - tailed Student's t - test, Mann - Whitney U - test, ANOVA, and SNK post - hoc test were used, but no OddsPath was calculated.",
                    "judgment": "No",
                    "reasoning": "The paper does not provide an OddsPath calculation for this variant.",
                    "next_step_or_outcome": "Proceed to Sub - step 4b"
                },
                {
                    "step_name": "Sub - step 4b: No OddsPath Calculation",
                    "extracted_paper_info": "Multiple mutants were tested, so the number of total benign/pathogenic variant controls used across the entire study for this variant's assay is likely more than 10.",
                    "judgment": "At least 11",
                    "reasoning": "Given that multiple mutants were part of the study, it is reasonable to assume that the total number of relevant variant controls is at least 11.",
                    "next_step_or_outcome": "Max PS3_moderate"
                }
            ],
            "final_evidence_strength": {
                "type": "Pathogenic",
                "strength": "PS3_moderate"
            },
            "overall_conclusion": "The disease mechanism for PD related to PINK1 was well - defined. The assays were appropriate. Basic controls, replicates, and variant controls were present. Since OddsPath was not calculated but the number of variant controls was likely at least 11, the functional evidence strength for the E231G variant is PS3_moderate for pathogenicity."
        },
        {
            "variant_id": {
                "Gene": "PINK1",
                "Protein_Change": {
                    "ref": "A",
                    "alt": "T",
                    "position": "339"
                },
                "variant_string_id": "PINK1 A339T"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "PINK1 mutations are associated with the loss of dopaminergic neurons in Parkinson disease.",
                    "judgment": "Yes",
                    "reasoning": "The paper clearly states the link between PINK1 mutations and the disease mechanism of dopaminergic neuron loss in PD.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "Assays for apoptosis, mitochondrial membrane potential, and time - dependent cell survival after oxidative stress were conducted.",
                    "judgment": "Yes",
                    "reasoning": "These assays are relevant to the PD disease mechanism as they can show the effects of PINK1 mutations on neuron viability under oxidative stress, which is involved in PD pathogenesis.",
                    "next_step_or_outcome": "Proceed to Step 3"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays",
                    "extracted_paper_info": "Experiments were performed in triplicate with wild - type cells as controls.",
                    "judgment": "Yes",
                    "reasoning": "Both basic controls (wild - type) and replicates were used, fulfilling the requirements for this step.",
                    "next_step_or_outcome": "Proceed to Sub - step 3c"
                },
                {
                    "step_name": "Sub - step 3c: Variant Controls",
                    "extracted_paper_info": "Other PINK1 mutants (p.R68P, p.E231G, p.I442T, p.D525N) were studied in the same experimental system.",
                    "judgment": "Yes",
                    "reasoning": "These other mutants can act as variant controls, even without clear prior classification as known pathogenic or benign.",
                    "next_step_or_outcome": "Proceed to Step 4"
                },
                {
                    "step_name": "Step 4: Apply evidence to individual variant interpretation",
                    "extracted_paper_info": "Statistical tests were used, but OddsPath was not calculated.",
                    "judgment": "No",
                    "reasoning": "The paper does not calculate OddsPath for the A339T variant.",
                    "next_step_or_outcome": "Proceed to Sub - step 4b"
                },
                {
                    "step_name": "Sub - step 4b: No OddsPath Calculation",
                    "extracted_paper_info": "With multiple mutants tested, the number of total benign/pathogenic variant controls used across the entire study for this variant's assay is likely more than 10.",
                    "judgment": "At least 11",
                    "reasoning": "As multiple mutants were part of the study, it is reasonable to assume that the total number of relevant variant controls is at least 11.",
                    "next_step_or_outcome": "Max PS3_moderate"
                }
            ],
            "final_evidence_strength": {
                "type": "Pathogenic",
                "strength": "PS3_moderate"
            },
            "overall_conclusion": "The disease mechanism of PD related to PINK1 was clearly defined. The assays were applicable. Basic controls, replicates, and variant controls were present. Since OddsPath was not calculated but the number of variant controls was likely at least 11, the functional evidence for the A339T variant is of PS3_moderate strength for pathogenicity."
        },
        {
            "variant_id": {
                "Gene": "PINK1",
                "Protein_Change": {
                    "ref": "I",
                    "alt": "T",
                    "position": "442"
                },
                "variant_string_id": "PINK1 I442T"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "Mutations in PINK1 are associated with the loss of dopaminergic neurons in Parkinson disease.",
                    "judgment": "Yes",
                    "reasoning": "The paper clearly defines the disease mechanism of PD as related to PINK1 - induced dopaminergic neuron loss.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "Apoptosis, mitochondrial membrane potential, and cell survival assays after oxidative stress were carried out.",
                    "judgment": "Yes",
                    "reasoning": "These assays are relevant to the PD disease mechanism as they can reflect the impact of PINK1 mutations on neuron function under oxidative stress, which is relevant to PD.",
                    "next_step_or_outcome": "Proceed to Step 3"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays",
                    "extracted_paper_info": "Experiments were performed in triplicate with wild - type cells as controls.",
                    "judgment": "Yes",
                    "reasoning": "Both basic controls (wild - type) and replicates were used, meeting the criteria for this step.",
                    "next_step_or_outcome": "Proceed to Sub - step 3c"
                },
                {
                    "step_name": "Sub - step 3c: Variant Controls",
                    "extracted_paper_info": "Other PINK1 mutants (p.R68P, p.E231G, p.A339T, p.D525N) were part of the study.",
                    "judgment": "Yes",
                    "reasoning": "These other mutants can serve as variant controls, even without prior clear classification as known pathogenic or benign.",
                    "next_step_or_outcome": "Proceed to Step 4"
                },
                {
                    "step_name": "Step 4: Apply evidence to individual variant interpretation",
                    "extracted_paper_info": "Statistical tests were used, but OddsPath was not calculated.",
                    "judgment": "No",
                    "reasoning": "The paper does not calculate OddsPath for the I442T variant.",
                    "next_step_or_outcome": "Proceed to Sub - step 4b"
                },
                {
                    "step_name": "Sub - step 4b: No OddsPath Calculation",
                    "extracted_paper_info": "With multiple mutants tested, the number of total benign/pathogenic variant controls used across the entire study for this variant's assay is likely more than 10.",
                    "judgment": "At least 11",
                    "reasoning": "Since multiple mutants were studied, it is reasonable to assume that the total number of relevant variant controls is at least 11.",
                    "next_step_or_outcome": "Max PS3_moderate"
                }
            ],
            "final_evidence_strength": {
                "type": "Pathogenic",
                "strength": "PS3_moderate"
            },
            "overall_conclusion": "The disease mechanism of PD related to PINK1 was well - defined. The assays were applicable. Basic controls, replicates, and variant controls were present. Since OddsPath was not calculated but the number of variant controls was likely at least 11, the functional evidence for the I442T variant has a PS3_moderate strength for pathogenicity."
        },
        {
            "variant_id": {
                "Gene": "PINK1",
                "Protein_Change": {
                    "ref": "D",
                    "alt": "N",
                    "position": "525"
                },
                "variant_string_id": "PINK1 D525N"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "PINK1 mutations are associated with the loss of dopaminergic neurons in Parkinson disease.",
                    "judgment": "Yes",
                    "reason